| Similar Articles |
|---|
 |
Nursing
July 2008
Daniel A. Hussar |
New Drugs08, Part 2 Here, you'll learn about eight new drugs, including doripenem, maraviroc and ixabepilone.   |
Nursing
August 2008
Carl A. Kirton |
Managing Long-Term Complications of HIV Infection Now that advances in treatment have transformed HIV into a chronic, manageable disease, patients are facing cardiovascular and metabolic complications you might not have expected 15 years ago. Here's how to help your patient manage them. |
Nursing
June 2010
Daniel A. Hussar |
New drugs 2010, part 2 In this article, you'll learn about 14 recently marketed new drugs. |
Nursing
January 2011
Carl A. Kirton |
HIV: The Changing Epidemic Since its emergence in the early 1980s, HIV infection in the United States has evolved from an acute debilitating condition to a chronic, treatable illness. |
Nursing
February 2010
Daniel A. Hussar |
New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs. |
Nursing
June 2011
Daniel A. Hussar |
New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis. |
Nursing
February 2009
Daniel A. Hussar |
New Drugs 09: Part 1 Learn about 10 new drugs, including nebivolol HCl, the newest beta-adrenergic blocking agent for hypertension. |
Nurse Practitioner
July 2010
Kristine A. Scordo |
Treating antiretroviral-induced dyslipidemia in HIV-infected adults Studies indicate that HIV-infected patients (both males and females) may be at an increased risk for the development of cardiovascular disease |
Nursing
March 2012
Daniel A. Hussar |
New Drugs 2012: part I In this article, you'll learn about 11 recently approved drugs. |
Nurse Practitioner
February 2011
Jennifer M. Belavic |
Annual Drug Update: 2010 in Review In 2010, the FDA approved several new drugs and new indications for use in primary care. From new therapies for adults with rheumatoid arthritis to a combination drug for benign prostatic hyperplasia, NPs need to be aware of the latest medications now available. |
American Family Physician
August 1, 2000
Sharon Scott Morey |
Practice Guidelines HHS Updates Guidelines for Antiretroviral Therapy in HIV Infection |
American Journal of Nursing
March 2010
Bradley-Springer et al. |
Every Nurse Is an HIV Nurse The evolution of HIV infection into a chronic disease has implications across all clinical care settings. Every nurse should be knowledgeable about the disease in order to provide high-quality care to people with or at risk for HIV. |
Nurse Practitioner
February 2012
Jennifer M. Belavic |
Annual drug update 2011 in review Many new medications were approved throughout 2011. This article will cover a variety of drugs that will be useful in nurse practitioner practice |
American Family Physician
November 1, 2003
Riedl & Casillas |
Adverse Drug Reactions: Types and Treatment Options Adverse drug reactions are common. Identifying true drug allergy, however, can be challenging. Complicating factors of drug reactions include the myriad clinical symptoms and multiple mechanisms of drug-host interaction, many of which are poorly understood. |
Nursing
May 2012
Tim Blake |
Three Medication Pathways for Bipolar Disorder No matter where you work, you're likely to care for patients with bipolar disorder, which affects about 2.6% of people age 18 and older per year. |
American Family Physician
September 1, 2000
Monica Preboth |
Clinical Briefs Diabetes in the School and Day Care Setting... Use of Rifamycins in HIV-Infected Patients... New Indication for Levofloxacin... NIAMS Bilingual Booklet for Patients with Arthritis... Consensus Statement on Chronic Tracheostomy... FDA Approves New Blood Glucose Device... Injuries and Violence Among Older Adults |
American Family Physician
January 1, 2001
Alex H. Krist |
Obstetric Care in Patients with HIV Disease Appropriate management of pregnant patients who have human immunodeficiency virus (HIV) disease can have a major impact on maternal and infant health... |
American Family Physician
August 15, 2006
Stump, Mayo & Blum |
Management of Grapefruit-Drug Interactions Grapefruit is a healthy addition to a well-balanced diet. However, the fruit has been shown to affect the metabolism of many medications, increasing the risk of toxicity and adverse effects. |
American Family Physician
November 15, 2002
Cynthia M. Williams |
Using Medications Appropriately in Older Adults Finding the right balance between too few and too many drugs will help ensure increased longevity, improved overall health, and enhanced functioning and quality of life for the aging population. |
American Journal of Nursing
March 2010
David E. Vance |
Aging with HIV: Clinical Considerations for an Emerging Population Since the advent of highly active antiretroviral therapy, HIV infection has become a chronic, albeit life-threatening, condition that can be managed; therefore, more and more people are growing older with HIV. |
American Family Physician
August 15, 2003 |
How to Take Your Medicines for HIV What should I know about my HIV medicines?... Why is it so important to take my medicine correctly?... What if I forget to take my pills?... Do I have to eat or drink something when I take my pills?... What are some of the more serious side effects of my medicines? |
American Family Physician
January 15, 2006
Ann M. Khalsa |
Preventive Counseling, Screening, and Therapy for the Patient with Newly Diagnosed HIV Infection The epidemic of HIV continues, and the infection is converting into a treatable chronic disease; therefore, it is increasingly important for family physicians to be current with and comfortable in providing basic care to patients infected with HIV. |
Nursing
November 2011
Jeanne Held-Warmkessel |
Taming Three High-Risk Chemotherapy Complications A review of three common chemotherapy-associated complications that can be serious enough to require hospitalization: febrile neutropenia, chemotherapy-related nephrotoxicity, and chemotherapy-related enterotoxicity. |
Nursing
February 2012
Pezzotti & Freuler |
Using anticoagulants to steer clear of clots This article will review coagulation and provide important information about several commonly used anticoagulants and their reversal agents. |
American Family Physician
May 15, 2002
Alex H. Krist & Amy Crawford-Faucher |
Management of Newborns Exposed to Maternal HIV Infection The management of infants whose mothers are infected with the human immunodeficiency virus involves minimizing the risk of vertical transmission of HIV, recognizing neonatal HIV infection early, preventing opportunistic infections, and addressing psychosocial issues... |
Nurse Practitioner
September 2010
Moloney & Cranwell-Bruce |
Pharmacological Management of Migraine Headaches Migraine is one of the top 20 causes of disability worldwide, occurring in 17.6% of women and 5.7% of men |
American Family Physician
December 1, 2005
Lawvere & Mahoney |
St. John's Wort The herb has been found to be superior to placebo and equivalent to standard antidepressants for the treatment of mild to moderate depression. St. John's wort is generally well tolerated, although it may potentially reduce the effectiveness of several pharmaceutical drugs. |
Nurse Practitioner
May 2011
Stacey A. Seggelke |
Hitting the target for inpatient glycemic management An understanding of glycemic treatment options for hospitalized patients is essential for good patient outcomes. |
Pharmaceutical Executive
December 1, 2005
Alana Klein |
Thought Leader: A Q&A with Graham Allaway While researchers continue to hunt for new AIDS drugs, Graham Allaway, chief operating officer of Panacos Pharmaceuticals, is focusing on developing a treatment for patients failing therapy due to resistance. |
American Family Physician
February 1, 2001
Eleftherios Mylonakis |
Plasma Viral Load Testing in the Management of HIV Infection In the 1990s, new technologies, including the polymerase chain reaction assay, the branched DNA assay and the nucleic acid sequence-based amplification assay, made it possible to obtain accurate quantitative measurements of human immunodeficiency virus (HIV) RNA in plasma... |
American Family Physician
March 15, 2005
Paul T. Giboney |
Mildly Elevated Liver Transaminase Levels in the Asymptomatic Patient Mild elevations in liver chemistry tests can reveal serious underlying conditions or have transient and benign etiologies. If elevations persist after an appropriate period of observation, further testing may include ultrasonography and other serum studies. |
American Family Physician
September 1, 2006
Gardiner & Dvorkin |
Promoting Medication Adherence in Children The problem of getting children to follow a treatment regimen is widespread and is frustrating for physicians. Having the child participate in devising the plan improves adherence. |
Nursing
October 2009
Yvonne D'Arcy |
Overturning barriers to pain relief in older adults This article will describe how to lower the barriers to effective pain control in older patients and provide practical tips for helping them receive the full benefit from pharmacologic and nonpharmacologic therapies. |
Nutrition Action Healthletter
September 2000 |
St. John's Wort and All Results from a new American study on the effectiveness of St. John's Wort for releaving depression, as well as possible interactions with other drugs. |
The Motley Fool
September 7, 2010
Luke Timmerman |
Vertex Nails Third Big Trial With Hepatitis C Drug And in the toughest patients to treat, too. |
Pharmaceutical Executive
December 1, 2010
Walter Armstrong |
The Next Wave: Pharm Exec's 2011 Pipeline Report 42 of the best new drugs in development or parked at the FDA |
The Motley Fool
November 29, 2010
Brian Orelli |
Head to Head: Merck vs. Itself Merck's HIV drug doesn't work as well when taken once daily. |
Pharmaceutical Executive
December 1, 2011
Ben Comer |
Pharm Exec's 2012 Pipeline Report It's a neck and neck race toward safer, faster, and medically superior treatments. Which organizations have what it takes to jockey their products into the winner's circle? |
The Motley Fool
August 10, 2010
Ryan McBride |
Vertex's Telaprevir Clears Hurdle, Could Halve Treatment Times for Hepatitis C Study results are positive. |
Pharmaceutical Executive
December 1, 2011
William Looney |
The Medicines Adherence Challenge Keeping skittish patients on their medicines ought to be a strategic priority for Big Pharma, but is it? An expert round table examines how best to make progress and agree on some practical steps for incorporation in the campaign agenda. |
American Family Physician
July 15, 2004
Joel E. Gallant |
HIV Counseling, Testing, and Referral By the year 2005, the CDC seeks to achieve the following: reduce annual new HIV infections from the current estimated 40,000 cases to 20,000 cases through the use of interventions such as counseling, HIV testing, and referral |
Chemistry World
March 2011 |
60 years of innovation To celebrate the international year of chemistry, James Mitchell Crow looks back at some of the discoveries and developments made by chemists over the past six decades |
The Motley Fool
September 8, 2010
Brian Orelli |
You Must Realize This Drug Works by Now Vertex concludes its phase 3 trials with another win. |
Pharmaceutical Executive
June 1, 2014
Ben Comer |
Take as Directed: From Force to Finesse in Promoting Adherence Healthcare players tout patient education and engagement as the keys to better drug adherence rates. Patients agree, as long as that translates to convenient and affordable access to therapy. |
Pharmaceutical Executive
November 1, 2012
Sue Barrowcliffe |
Real World Insights Commercial teams as well as patients can benefit from managed access programs, which are designed to provide access to medicines outside of the clinical and commercial setting, for patients who have no other available treatment options. |
Pharmaceutical Executive
August 1, 2011
Jennifer Ringler |
The Adherence Fight: A TKO? Why does the match against medicines compliance always seem to end in an easy knockout? |
American Family Physician
May 15, 2003
Paul Gross |
Diary from a Week in Practice Prader-Willi syndrome is a learning opportunity... Is there any antiretroviral regimen that can minimize liver toxicity and lipodystrophy?... Often, the most precious medicine we offer is neither pill nor liquid, but merely our caring presence... etc. |
Popular Mechanics
December 1, 2006
Ben Harder |
Fighting HIV by Building a New Killer In the fight to find a cure for AIDS, researchers have invented a viral double agent on a mission to seek out where HIV hides. |
Chemistry World
July 11, 2012 |
Gsk Drug Shines in HIV Trial GlaxoSmithKline has announced good results for its HIV - Aids drug candidate dolutegravir, which has apparently outperformed Atripla tablets in Phase III. |
The Motley Fool
March 31, 2011
Brian Orelli |
Hepatitis C Drugs Heat Up The current hepatitis C drugs stink. Who's ahead in the race to find new ones? |
